Craig C. Hopkinson

Insider Reports History

Identity
Location
Waltham, MA
SEC record
Reporting signature
/s/ Shantale Greenson, attorney-in-fact for Craig C. Hopkinson
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Craig C. Hopkinson:

Form 4 holding EVP R&D, Chief Medical Officer

Alkermes plc.

Security class
Ordinary Shares
Shares / value
81,389
Estimated value
$2,718,026
Report date
01 May 2026
Price
$33.40
Ownership
Direct
Form 4 holding EVP R&D, Chief Medical Officer

Alkermes plc.

Security class
Restricted Stock Unit Award
Shares / value
38,568
Estimated value
Report date
02 Mar 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding EVP R&D, Chief Medical Officer

Alkermes plc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
11,356
Estimated value
Report date
01 May 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

ALBIREO PHARMA, INC.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
02 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Craig C. Hopkinson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .